CLM Exam 1 Drugs 1.27.20 Flashcards
bimatoprost
Latisse, Lumigan
cetirizine
Zyrtec
diphenhydramine
Benadryl
formoterol/budesonide
Symbicort
hydroxychloroquine
Plaquenil
indomethacin
Indocin
ketorolac
Toradol
latanoprost
Xaltan
levocetirizine
Xyzal
loratadine
Claritin
methotrexate
Trexall
montelukast
Singulair
morphine
Duramorph, Kadian, MS Contin
oxycodone
OxyContin, Roxicodone
prednisone
Deltasone
bimatoprost (Latisse, Lumigan) class
agent for glaucoma
bimatoprost (Latisse, Lumigan) FDA uses
open-angle glaucoma, ocular hypertension, hypotrichosis of the eyelashes
bimatoprost (Latisse, Lumigan) MOA
synthetic prostaglandin analog; lowers IOP by increasing outflow of aqueous humor through the trabecular meshwork & uveoscleral drainage systems. The MOA for eyelash growth is unknown. It may work by increasing the duration & % of hairs in the anagen or growth phase.
bimatoprost (Latisse, Lumigan) MCP
- may permanently increase iris pigmentation
- hair growth is possible on skin surfaces after repeated contact with drug
- remove contact lenses before administration; reinsert after 15 minutes
- do not instill multiple ophthalmic products; allow at least 5 minutes between
cetirizine (Zyrtec) class
antihistamine
cetirizine (Zyrtec) FDA uses
- allergic conjunctivitis
- allergic rhinitis due to pollen
- urticaria (hives) acute or chronic
- perennial allergic rhinitis
- upper respiratory tract allergy
cetirizine (Zyrtec) MOA
human metabolite of hydroxyzine that selectively inhibits effects of peripheral H1 receptors
cetirizine (Zyrtec)
- ophthalmic use: remove contacts, reinsert after 10 minutes
- avoid alcohol & other CNS depressants
diphenhydramine (Benadryl) class
antihistamine